Scarica l'app Stockscreener
1.68
1.20%
0.02
Dopo l'orario di chiusura:
1.65
-0.03
-1.79%
Precedente Chiudi:
$1.66
Aprire:
$1.67
Volume 24 ore:
1.25M
Relative Volume:
1.70
Capitalizzazione di mercato:
$205.64M
Reddito:
$108.81M
Utile/perdita netta:
$-186.70M
Rapporto P/E:
-1.9952
EPS:
-0.842
Flusso di cassa netto:
$-16.83M
1 W Prestazione:
+12.00%
1M Prestazione:
-0.59%
6M Prestazione:
+12.75%
1 anno Prestazione:
-17.24%
Intervallo 1D:
$1.61
$1.73
Intervallo di 1 settimana:
$1.43
$1.74
Portata 52W:
$1.31
$2.91
Organigram Holdings Inc Stock (OGI) Company Profile
Confronta OGI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OGI
Organigram Holdings Inc
|
1.68 | 205.64M | 108.81M | -186.70M | -16.83M | -0.842 |
|
ZTS
Zoetis Inc
|
171.43 | 77.44B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.55 | 43.22B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.53 | 42.94B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.83 | 18.94B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
127.01 | 13.51B | 612.78M | -86.37M | -62.91M | -0.87 |
Organigram Holdings Inc Stock (OGI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-17 | Ripresa | Canaccord Genuity | Speculative Buy |
| 2024-04-15 | Aggiornamento | Alliance Global Partners | Neutral → Buy |
| 2023-01-13 | Aggiornamento | Stifel | Hold → Buy |
| 2022-01-12 | Aggiornamento | Canaccord Genuity | Hold → Speculative Buy |
| 2021-05-11 | Aggiornamento | CIBC | Sector Underperform → Neutral |
| 2021-04-14 | Downgrade | CIBC | Neutral → Sector Underperform |
| 2021-04-08 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2021-03-10 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-13 | Downgrade | Alliance Global Partners | Buy → Neutral |
| 2021-01-13 | Downgrade | Canaccord Genuity | Speculative Buy → Hold |
| 2020-07-07 | Iniziato | Alliance Global Partners | Buy |
| 2020-01-15 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-01-13 | Iniziato | BofA/Merrill | Underperform |
| 2020-01-09 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-11-12 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2019-11-05 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-10-11 | Aggiornamento | Jefferies | Hold → Buy |
Mostra tutto
Organigram Holdings Inc Borsa (OGI) Ultime notizie
Organigram (OGI) to Release Quarterly Earnings on Tuesday - MarketBeat
Organigram (TSE:OGI) Shares Down 4.5%Time to Sell? - MarketBeat
Organigram Holdings to Announce Q1 Fiscal 2025 Results - TipRanks
Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025 - The Bakersfield Californian
Organigram (TSE:OGI) Shares Down 4.5% – Here’s What Happened - Defense World
Head-To-Head Survey: Oncternal Therapeutics (NASDAQ:ONCT) & Organigram (NASDAQ:OGI) - Defense World
OGIOrganigram Announces $60 Million Underwritten Public Offering - ADVFN Logo
OGI (OrganiGram Holdings) Debt-to-Revenue : 0.03 (As of Sep. 2024) - GuruFocus.com
OGI (OrganiGram Holdings) 3-Year Book Growth Rate : -22.90% (As of Sep. 2024) - GuruFocus.com
OrganiGram Holdings (NASDAQ:OGI) Stock Quotes, Forecast and News Summary - Benzinga
Cannabidiol Cbd Water Market Expected to Boom at 13.89% CAGR to Hit 7.183 Billion USD by 2032 | Organigram - EIN News
OrganiGram Holdings (FRA:0OG0) Operating Cash Flow per Shar - GuruFocus.com
Organigram (NASDAQ:OGI) Shares Down 1.3% – Should You Sell? - Defense World
Organigram (NASDAQ:OGI) Trading Down 1.3% – Here’s What Happened - Defense World
Organigram (NASDAQ:OGI) Trading Down 1.3%What's Next? - MarketBeat
OrganiGram Holdings (FRA:0OG0) Cash Flow for Lease Financin - GuruFocus.com
OrganiGram Holdings (FRA:0OG0) Long-Term Capital Lease Obli - GuruFocus.com
OrganiGram Holdings (FRA:0OG0) Free Cash Flow per Share : €0.02 (TTM As of Sep. 2024) - GuruFocus.com
Organigram (TSE:OGI) Stock Price Down 0.4%Here's Why - MarketBeat
OrganiGram Holdings (STU:0OG0) EPS without NRI : €-0.34 (TTM As of Sep. 2024) - GuruFocus.com
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On - Benzinga
Why OrganiGram (OGI) Is Among the Best Pot Stocks to Invest in According to Analysts? - Yahoo Finance
10 Best Pot Stocks To Invest In According to Analysts - Insider Monkey
Canada’s Organigram shops for U.S. pot businesses with backing from British American Tobacco - MSN
Atb Cap Markets Predicts Organigram Q1 Earnings - MarketBeat
Alliance Global Partners Comments on Organigram Q1 Earnings - MarketBeat
Alliance Global Partners Predicts Organigram Q1 Earnings - MarketBeat
Organigram: Long Term Growth Improving With International And Domestic Cannabis Expansion (Rating Upgrade) - Seeking Alpha
Atb Cap Markets Estimates Organigram’s Q4 Earnings (TSE:OGI) - Defense World
Organigram Reports Fourth Quarter and Fiscal 2024 Results - Business Wire
OrganiGram Holdings Inc. (NASDAQ:OGI) Q4 2024 Earnings Call Transcript - Insider Monkey
Atb Cap Markets Estimates Organigram Q4 Earnings - MarketBeat
Atb Cap Markets Forecasts Organigram Q3 Earnings - MarketBeat
Small caps to watch: Shares in Canadian fashion retailer slide after disappointing quarter - The Globe and Mail
FY2025 EPS Estimates for Organigram Cut by Atb Cap Markets - MarketBeat
OrganiGram Holdings Inc (OGI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Organigram eyes global cannabis growth after Motif deal - Green Market Report
OrganiGram Holdings Inc (OGI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion - GuruFocus.com
OrganiGram: Fiscal Q4 Earnings Snapshot - CT Insider
OrganiGram Holdings Inc (OGI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
The small-cap rally has its skeptics: Morning Brief [Video] - AOL
Organigram Holdings: Fiscal 2024 Financial Highlights - TipRanks
Organigram (OGI) Q4 2024 Earnings Call Transcript - The Motley Fool
Organigram Reports Revenue Growth in Fiscal 2024, But Net Losses Continue - The Deep Dive
Organigram (NASDAQ:OGI) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat
Organigram tops estimates, expands international reach ahead of major deal - Green Market Report
Cannabis Player Organigram Clocks Q4 Gross Margin Of 37% On Higher Efficiency Across Cultivation And Higher Recreational Sales, Stock Soars - Benzinga
OrganiGram Holdings 4Q Profit, Revenue Rise - MarketWatch
Organigram Acquires Motif Labs, Becomes Canada’s Largest Cannabis Company - Yahoo Finance
Organigram Increases Revenue and Adjusted EBITDA in Q4 - New Cannabis Ventures
OrganiGram Holdings Q4 Earnings AssessmentOrganiGram Holdings (NASDAQ:OGI) - Benzinga
Organigram Holdings Inc Azioni (OGI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.57%
3.76%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):